Skip to Content

TEVA 7334 (Mycophenolate mofetil 250 mg)

This pill with imprint "TEVA 7334" is Blue & Orange, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is manufactured by Teva Pharmaceuticals USA.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; myasthenia gravis; rheumatoid arthritis; bullous pemphigoid (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil
TEVA 7334
250 mg
Blue & Orange
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.